Abezino 150 mg is a tablet product of Healthcare Pharmaceuticals Ltd. that contains Abemaciclib. It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate.
There are 6 brands of Abemaciclib listed in Bangladesh. By unit price, Abezino is among the cheapest of them. The lowest listed price is Abeza 150 mg Tablet at ৳ 950.00 per unit.
What is Abezino 150 mg Tablet?
Made by Healthcare Pharmaceuticals Ltd., Abezino is a tablet whose active ingredient is Abemaciclib. Abezino 150 mg tablet is a cancer medicine containing Abemaciclib, which belongs to a group called protein kinase inhibitors. Because it is a cancer medicine, it is started and supervised only by a qualified cancer specialist. Do not change or stop the medicine unless your doctor tells you to.
Uses of Abezino
It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate. Do not use it for any other condition without medical advice. It is not a general-purpose medicine and should only be used under cancer specialist care. Ask your doctor whether it is right for your condition.
How to use Abezino
If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do rather than guessing. Abezino is taken by mouth. Swallow the tablet with water. The doctor decides the dose and how long you take it, and may change the schedule depending on how you tolerate it. Complete the course exactly as prescribed.
Side effects of Abezino
Blood counts can also drop, which may show up as low white cells, low red cells or low platelets. Some people may develop severe diarrhea with dehydration or infection, or lung problems. Your doctor will advise on managing side effects. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Some medicines, including certain antifungals and antibiotics, can affect how Abemaciclib works, so always tell the doctor or pharmacist about everything you take. Women who could become pregnant should use effective contraception during treatment and for a period after the last dose as advised by the doctor. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
Frequently asked questions
What does Abezino treat?
It is meant for patients whose doctor has confirmed the cancer type and stage and decided that this medicine is appropriate. Do not use it for any other condition without medical advice.
How is Abezino used?
If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do rather than guessing. Abezino is taken by mouth.
What should I watch for while using Abezino?
Blood counts can also drop, which may show up as low white cells, low red cells or low platelets. Some people may develop severe diarrhea with dehydration or infection, or lung problems.
in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
... Read more
Abezino is a kinase inhibitor indicated:
in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.
Pharmacology
Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4/6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. In vitro, continuous exposure to abemaciclib inhibited Rb phosphorylation and blocked progression from G1 into S phase of the cell cycle, resulting in senescence and apoptosis. In breast cancer xenograft models, abemaciclib dosed daily without interruption as a single agent or in combination with antiestrogens resulted in reduction of tumor size.
Dosage & Administration
Abemaciclib tablets are taken orally with or without food.
Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily.
Recommended starting dose as monotherapy: 200 mg twice daily.
Dosing interruption and/or dose reductions may be required based on individual safety and tolerability.
Interaction
CYP3A Inhibitors: Avoid concomitant use of ketoconazole. Reduce the Abezino dose with concomitant use of other strong and moderate CYP3A inhibitors. CYP3A Inducers: Avoid concomitant use of strong and moderate CYP3A inducers.
Side Effects
Most common adverse reactions (incidence ≥20%) were diarrhea, neutropenia, nausea, abdominal pain, infections, fatigue, anemia, leukopenia, decreased appetite, vomiting, headache, alopecia, and thrombocytopenia.
Pregnancy & Lactation
Based on findings from animal studies and the mechanism of action, Abemaciclib can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Abemaciclib and for 3 weeks after the last dose.
Precautions & Warnings
Diarrhea: Abezino can cause severe cases of diarrhea, associated with dehydration and infection. Instruct patients at the first sign of loose stools to initiate antidiarrheal therapy, increase oral fluids, and notify their healthcare provider.
Neutropenia: Monitor complete blood counts prior to the start of Abezino therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated.
Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of ILD/pneumonitis have been reported. Monitor for clinical symptoms or radiological changes indicative of ILD/pneumonitis. Permanently discontinue Abezino in all patients with Grade 3 or 4 ILD or pneumonitis.
Hepatotoxicity: Increases in serum transaminase levels have been observed. Perform liver function tests (LFTs) before initiating treatment with Abezino. Monitor LFTs every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated.
Venous Thromboembolism: Monitor patients for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate.
Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of potential
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Alternative brands of Abemaciclib
Other brands with the same generic name, cheapest first.